Teladoc Health Inc’s recent filing unveils that its Chief Technology Officer Nanis Nikolaos P. unloaded Company’s shares for reported $6599.0 on Apr 02 ’24. In the deal valued at $14.31 per share,461 shares were sold. As a result of this transaction, Nanis Nikolaos P. now holds 70,621 shares worth roughly $1.0 million.
Then, Geshuri Arnnon sold 7,500 shares, generating $112,950 in total proceeds. Upon selling the shares at $15.06, the CHIEF PEOPLE OFFICER now owns 38,470 shares.
Before that, Trencher Daniel sold 1,000 shares. Teladoc Health Inc shares valued at $15,180 were divested by the CHIEF STRATEGY OFFICER at a price of $15.18 per share. As a result of the transaction, Trencher Daniel now holds 27,192 shares, worth roughly $0.39 million.
Cantor Fitzgerald initiated its Teladoc Health Inc [TDOC] rating to an Overweight in a research note published on February 29, 2024; the price target was $22. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in late February with a ‘”a Market perform”‘ rating. DA Davidson also remained covering TDOC and has decreased its forecast on January 17, 2024 with a “Neutral” recommendation from previously “Buy” rating. Barclays started covering the stock on January 03, 2024. It rated TDOC as “an Overweight”.
Price Performance Review of TDOC
On Friday, Teladoc Health Inc [NYSE:TDOC] saw its stock fall -2.67% to $14.21. Over the last five days, the stock has lost -1.93%. Teladoc Health Inc shares have fallen nearly -34.06% since the year began. Nevertheless, the stocks have fallen -43.70% over the past one year. While a 52-week high of $30.41 was reached on 01/02/24, a 52-week low of $13.59 was recorded on 04/05/24. SMA at 50 days reached $16.34, while 200 days put it at $19.81. A total of 4.92 million shares were traded, compared to the trading of 3.41 million shares in the previous session.
Levels Of Support And Resistance For TDOC Stock
The 24-hour chart illustrates a support level at 14.08, which if violated will result in even more drops to 13.95. On the upside, there is a resistance level at 14.47. A further resistance level may holdings at 14.74. The Relative Strength Index (RSI) on the 14-day chart is 37.77, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.26, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 66.39%. Stochastics %K at 43.97% indicates the stock is a holding.
The most recent change occurred on April 12, 2023 when Stephens began covering the stock and recommended ‘”an Equal-weight”‘ rating along with a $25 price target.
